Yes. As of September 2026, Danaher Corporation (DHR) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones Islamic, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 17.1% / 30% · (Cash+Inv) / Mkt Cap (36m) 4.67% / 30% · Interest income / Revenue 0.47% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 17.1% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.66% / 33% · Receivables / Mkt Cap (36m) 3.30% / 49% · Interest income / Revenue 0.47% / 5% | Pass |
| Dow Jones Islamic | Debt / Mkt Cap (24m) 17.1% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.66% / 33.33% · Receivables / Mkt Cap (24m) 3.30% / 33.33% · Interest income / Revenue 0.47% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 25.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 5.77% / 33.33% · Receivables / Avg Assets (4Q) 4.77% / 33.33% · Interest income / Revenue 0.47% / 5% | Pass |
| FTSE | Debt / Total Assets 28.4% / 33.33% · (Cash+ST Inv) / Total Assets 6.09% / 33.33% · (Cash+Recv) / Total Assets 11.6% / 33.33% · Interest income / Revenue 0.47% / 5% | Pass |
Yes. As of September 2026, Danaher Corporation (DHR) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones Islamic, MSCI and FTSE).
Yes. Danaher Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.47% of each dividend: Danaher Corporation's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 25, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Danaher Corporation (NYSE: DHR) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $161.9B. The Maz Rating grades it against the other companies in its sector.
Danaher Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $230.15, Danaher Corporation trades at 37.6x trailing earnings, 6.3x sales and 3.0x book value, with an EV/EBITDA of 25.8. Over the last twelve months it generated about $25.6B of revenue and $4.3B of net income. It runs a gross margin of 58.6%, an operating margin of 20.4% and a net margin of 16.9%. It shows return on equity of 8.2%, return on invested capital of 5.4% and a free cash flow yield of 3.5%. On the balance sheet: a debt-to-equity ratio of 0.49 and a current ratio of 1.63. Over the past 52 weeks the share price ranged from $160.93 to $242.80, with a beta of 0.80.
Danaher Corporation pays a dividend yielding 0.66%, with 23% of earnings paid out. Its Maz Dividend Score is 4.50 out of 5, ranked against the other dividend payers in its sector (Safety 3.63, Growth 4.90, Yield 1.77, Consistency 3.81).
43 Wall Street analyst ratings cover the stock: 1 Strong Buy, 30 Buy, 11 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.